Global chemical hazard labeling system would confuse consumers if applied to pharmaceuticals -- PhRMA.
Executive Summary
GLOBALIZED CHEMICAL HAZARD LABELING WOULD BE "SOURCE OF CONFUSION," PhRMA VP-Manufacturing & Quality Control Thomas White maintained at a State Department meeting on international harmonization of chemical safety and health information June 5 in Washington, D.C. Patients and other users "would be needlessly alarmed and confused by labeling that is inappropriate and has no relevance to the safe and effective use of pharmaceuticals for their intended therapeutic indications," the Pharmaceutical Research & Manufacturers of America maintained in response to a Federal Register notice on the harmonization initiative.